Know Cancer

or
forgot password

Phase I Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) With Patients With Head and Neck Tumor


Phase 1
18 Years
N/A
Not Enrolling
Both
Head and Neck Tumor

Thank you

Trial Information

Phase I Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) With Patients With Head and Neck Tumor


Inclusion Criteria:



- Head and neck tumor

- Aged > 18 years

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Tumor recurrences

Principal Investigator

Wilfried De Neve, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University Hospital, Ghent

Authority:

Belgium: Institutional Review Board

Study ID:

2006/391

NCT ID:

NCT00406289

Start Date:

November 2006

Completion Date:

February 2010

Related Keywords:

  • Head and Neck Tumor
  • Head and Neck Neoplasms

Name

Location